Man Group plc Acquires 77,810 Shares of Maximus, Inc. (NYSE:MMS)

Man Group plc grew its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 53.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 223,297 shares of the health services provider's stock after buying an additional 77,810 shares during the period. Man Group plc owned 0.39% of Maximus worth $16,669,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of the business. UMB Bank n.a. boosted its stake in shares of Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after purchasing an additional 158 shares during the period. V Square Quantitative Management LLC increased its holdings in Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after buying an additional 180 shares during the period. R Squared Ltd acquired a new stake in shares of Maximus during the 4th quarter worth approximately $54,000. IFP Advisors Inc lifted its position in shares of Maximus by 62.4% during the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after buying an additional 302 shares in the last quarter. Finally, Farther Finance Advisors LLC lifted its position in shares of Maximus by 109.2% during the 4th quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider's stock valued at $61,000 after buying an additional 428 shares in the last quarter. Institutional investors own 97.21% of the company's stock.

Maximus Price Performance

Shares of NYSE:MMS traded down $0.37 on Tuesday, hitting $74.80. The company had a trading volume of 273,247 shares, compared to its average volume of 561,550. The business has a 50 day moving average of $68.88 and a 200 day moving average of $72.47. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97. The company has a market cap of $4.21 billion, a PE ratio of 16.09 and a beta of 0.61. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.37 by $0.64. The business had revenue of $1.36 billion during the quarter, compared to analyst estimates of $1.29 billion. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The company's revenue for the quarter was up 1.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.57 earnings per share. As a group, equities analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be given a $0.30 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.60%. Maximus's dividend payout ratio is currently 23.86%.

Insider Buying and Selling

In related news, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares in the company, valued at $1,225,347.87. This represents a 11.88% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the sale, the insider now directly owns 2,512 shares of the company's stock, valued at approximately $171,167.68. The trade was a 85.23% decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.